All Search Results
News Releases
30 Sep, 2026, 21:45 GMT Global Dimethyl Carbonate Market to Reach USD 2.15 Bn. by 2034 as Battery Electrolyte Demand, EV Growth and High-Purity Solvent Applications Accelerate Market Expansion, says Maximize Market Research
the Global Dimethyl Carbonate market report?Ans: The Global Dimethyl Carbonate Market report helps with the PESTEL, PORTER, and COVID-19 Impact analysis, Recommendations for Investors and leaders, and market estimation for the forecast period.4. Who are the key players in
More news about: Maximize Market Research Pvt. Ltd.
28 Sep, 2026, 14:30 GMT Telehealth and Telemedicine Market worth $198.9 billion by 2031 - Exclusive Report by MarketsandMarkets™
increased Medicare reimbursement for RPM services) and cost savings from preventing hospital readmissions contribute to accelerating this growth. The COVID-19 pandemic accelerated RPM adoption, as healthcare providers sought ways to track patients remotely and maintain continuity of care without the risks
More news about: MarketsandMarkets
24 Sep, 2026, 07:41 GMT The Coffee Bean & Tea Leaf® and Al-Ghunaim Celebrate 130-Café Milestone in Kuwait
been central to this journey. His vision and leadership have guided the business through rapid expansion, changing consumer preferences, the COVID-19 pandemic and ongoing regional uncertainty, while maintaining a strong focus on customer experience."Reaching this milestone is a meaningful
More news about: The Coffee Bean & Tea Leaf®
22 Sep, 2026, 19:42 GMT Lateral Flow Assay Market to Reach US$ 16.37 Bn by 2031, Growing at 8.2% CAGR: New Report by Wissen Research
aging population and growing focus on preventive healthcare. Continued high consumption of home-based diagnostic kits — a habit reinforced during the COVID-19 pandemic and now extending into pregnancy, fertility, and chronic-disease self-monitoring — is sustaining demand across hospitals, clinics, and home-care
More news about: Wissen Research LLC
21 Sep, 2026, 14:31 GMT Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight
ClinicalTrials.gov, the Phase III ATALANTE-1 trial evaluating OSE-2101 in patients with advanced or metastatic NSCLC was terminated prematurely due to the COVID-19 pandemic. However, encouraging overall survival outcomes observed in patients with secondary resistance to immune checkpoint inhibitors (ICIs) supported
More news about: DelveInsight Business Research, LLP
